{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:51:41Z","timestamp":1791939101346,"version":"4.3.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1995,1]]},"DOI":"10.1038\/nm0195-27","type":"journal-article","created":{"date-parts":[[2004,8,18]],"date-time":"2004-08-18T21:04:00Z","timestamp":1092863040000},"page":"27-30","source":"Crossref","is-referenced-by-count":6090,"title":["Angiogenesis in cancer, vascular, rheumatoid and other disease"],"prefix":"10.1038","volume":"1","author":[{"given":"Judah","family":"Folkman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnm019527_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/jnci\/86.1.45","volume":"86","author":"R Demicheli","year":"1994","unstructured":"Demicheli, R. et al. Local recurrences following mastectomy: support for the concept of tumor dormancy.J, natn. Cancer Inst. 86, 45\u201348 (1994).","journal-title":"Cancer Inst."},{"key":"BFnm019527_CR2","first-page":"211","volume":"18","author":"M Morrow","year":"1993","unstructured":"Morrow, M. & Jordan, V.C. Risk factors and the prevention of breast cancer with tamoxifen. Cancer Surveys 18, 211\u2013229 (1993).","journal-title":"Cancer Surveys"},{"key":"BFnm019527_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/jnci\/80.10.722","volume":"80","author":"ML Kripke","year":"1988","unstructured":"Kripke, M.L. Immunoregulation of carcinogenesis: past, present, and future. J. natn. Cancer Inst. 80, 722\u2013727 (1988).","journal-title":"J. natn. Cancer Inst."},{"key":"BFnm019527_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0147-0272(79)80008-2","volume":"3","author":"EV Sugarbaker","year":"1979","unstructured":"Sugarbaker, E.V. Cancer metastasis: a product of tumor-host interactions. Curr. Prob. Cancer 3, 1\u201359 (1979).","journal-title":"Curr. Prob. Cancer"},{"key":"BFnm019527_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0092-8674(94)90187-2","volume":"79","author":"IJ Fider","year":"1994","unstructured":"Fider, I.J. & Ellis, L.M. Cell 79, 185\u2013188 (1994).","journal-title":"Cell"},{"key":"BFnm019527_CR6","first-page":"2","volume":"51","author":"RT Prehn","year":"1991","unstructured":"Prehn, R.T. The inhibition of tumor growth by tumor mass. Cancer Res. 51, 2\u20134 (1991).","journal-title":"Cancer Res."},{"key":"BFnm019527_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/339058a0","volume":"339","author":"J Folkman","year":"1989","unstructured":"Folkman, J., Watson, K. Ingber & D. Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339, 58\u201361 (1989).","journal-title":"Nature"},{"key":"BFnm019527_CR8","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/0092-8674(91)90033-U","volume":"66","author":"J Kandel","year":"1991","unstructured":"Kandel, J. et al. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66, 1095\u20131104 (1991).","journal-title":"Cell"},{"key":"BFnm019527_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199101033240101","volume":"324","author":"N Weidner","year":"1991","unstructured":"Weidner, N., Semple, J., Welch, W. & Folkman, J. Tumor angiogenesis correlates with metastasis in invasive breast carcinoma. N. Engl. J. Med. 324, 1\u20138 (1991).","journal-title":"N. Engl. J. Med."},{"key":"BFnm019527_CR10","volume-title":"The Molecular Basis of Cancer","author":"J Folkman","year":"1994","unstructured":"Folkman, J. Tumor angiogenesis. In: Mendelsohn, J., Howley, P., Liotta, L., Israel, M., eds. The Molecular Basis of Cancer, W.B. Saunders Company, Philadelphia, in press (1994)."},{"key":"BFnm019527_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1200\/JCO.1994.12.3.441","volume":"12","author":"J Folkman","year":"1994","unstructured":"Folkman, J. Angiogenesis and breast cancer. J. clin. Oncol 12, 441\u2013443 (1994).","journal-title":"J. clin. Oncol"},{"key":"BFnm019527_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF00119076","volume":"4","author":"RF Nicosia","year":"1986","unstructured":"Nicosia, R.F., Tchao, R. & Leighton, J. Interactions between newly formed en-dothelial channels and carcinoma cells in plasma clot culture. Clin. exp. Metastasis. 4, 91\u2013104 (1986).","journal-title":"Clin. exp. Metastasis."},{"key":"BFnm019527_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/jcp.1041590208","volume":"159","author":"JW Rak","year":"1994","unstructured":"Rak, J.W., Hegmann, E.J., Lu, C. & Kerbel, R.S. Progressive loss of sensitivity to en-dothelium-derived growth inhibitors expressed by human melanoma cells during disease progression. J. cell. Physiol. 159, 245\u2013255 (1994).","journal-title":"J. cell. Physiol."},{"key":"BFnm019527_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/bjc.1992.269","volume":"66","author":"J Hamada","year":"1992","unstructured":"Hamada, J., Cavanaugh, P.G., Lotan, O. & Nicolson, G. Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothe-lial cells derived from target organs for metastasis. Br. J. Cancer 66, 349\u2013354 (1992).","journal-title":"Br. J. Cancer"},{"key":"BFnm019527_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0092-8674(89)90238-9","volume":"56","author":"F Rastinejad","year":"1989","unstructured":"Rastinejad, F., Polveini, P.J. & Bouck, N.P. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56, 345\u2013355 (1989).","journal-title":"Cell"},{"key":"BFnm019527_CR16","first-page":"179","volume":"2","author":"NP Bouck","year":"1990","unstructured":"Bouck, N.P. Tumor angiogenesis: the role of oncogenes and tumor suppressor gene. Cancer Cells. 2, 179\u2013185 (1990).","journal-title":"Cancer Cells."},{"key":"BFnm019527_CR17","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1126\/science.7521539","volume":"265","author":"KM Dameron","year":"1994","unstructured":"Dameron, K.M., Volpert, O.V., Tainsky, M.A. & Bouck, N.P. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582\u20131584 (1994).","journal-title":"Science"},{"key":"BFnm019527_CR18","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1126\/science.6382607","volume":"225","author":"T Maciag","year":"1984","unstructured":"Maciag, T., Mehlman, T., Friesel, R. & Schreiber, A. Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain. Science 225, 932\u2013935 (1984).","journal-title":"Science"},{"key":"BFnm019527_CR19","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1126\/science.6199844","volume":"223","author":"Y Shing","year":"1984","unstructured":"Shing, Y. et al. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 223, 1296\u20131298 (1984).","journal-title":"Science"},{"key":"BFnm019527_CR20","first-page":"851","volume":"161","author":"N Ferrara","year":"1989","unstructured":"Ferrara, N. & Henzel, W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Com-mun. 161, 851\u2013855 (1989).","journal-title":"Res. Com-mun."},{"key":"BFnm019527_CR21","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.1021\/bi00341a030","volume":"24","author":"JW Fett","year":"1985","unstructured":"Fett, J.W. et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochem. 24, 5480\u20135486 (1985).","journal-title":"Biochem."},{"key":"BFnm019527_CR22","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1016\/S0021-9258(19)49853-0","volume":"267","author":"J Folkman","year":"1992","unstructured":"Folkman, J., Shing, Y., J. biol Chem. 267, 10931\u201310934 (1992).","journal-title":"J. biol Chem."},{"key":"BFnm019527_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","volume":"79","author":"S O'Reilly","year":"1994","unstructured":"O'Reilly, S. et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315\u2013328 (1994).","journal-title":"Cell"},{"key":"BFnm019527_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng1094-171","volume":"8","author":"EG Van Meir","year":"1994","unstructured":"Van Meir, E.G. et al. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nature Genetics 8, 171\u2013176 (1994).","journal-title":"Nature Genetics"},{"key":"BFnm019527_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/283139a0","volume":"283","author":"G Poste","year":"1980","unstructured":"Poste, G. & Fidler, I.J. The pathogenesis of cancer metastasis. Nature 283, 139\u2013146 (1980).","journal-title":"Nature"},{"key":"BFnm019527_CR26","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJM199003013220907","volume":"322","author":"B Zetter","year":"1990","unstructured":"Zetter, B. The cellular basis of site-specific tumor metastasis. N. Engl. J. Med. 322, 605\u2013612 (1990).","journal-title":"N. Engl. J. Med."},{"key":"BFnm019527_CR27","unstructured":"Holmgren, L., O'Reilly, M. & Folkman, J. in press (1994)."},{"key":"BFnm019527_CR28","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1172\/JCI117018","volume":"93","author":"S Takeshita","year":"1994","unstructured":"Takeshita, S. et al. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. clin. Invest 93, 662\u2013670 (1994).","journal-title":"J. clin. Invest"},{"key":"BFnm019527_CR29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/359843a0","volume":"359","author":"D Shweiki","year":"1992","unstructured":"Shweiki, D., Itin, A., Soffer, D. & Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843\u2013845 (1992).","journal-title":"Nature"},{"key":"BFnm019527_CR30","unstructured":"Ferrara, N. personal communication (1994)."},{"key":"BFnm019527_CR31","first-page":"2005","volume":"34","author":"JM Yuhas","year":"1974","unstructured":"Yuhas, J.M. & Pazmino, N.H. Inhibition of subcutaneously growing line 1 carcinomas due to metastatic spread. Cancer Res. 34, 2005\u20132010 (1974).","journal-title":"Cancer Res."},{"key":"BFnm019527_CR32","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1093\/jnci\/85.19.1597","volume":"85","author":"D Nanus","year":"1993","unstructured":"Nanus, D. et al. Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J. natn. Cancer Inst. 85, 1597\u20131599 (1993).","journal-title":"J. natn. Cancer Inst."},{"key":"BFnm019527_CR33","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/jnci\/86.5.356","volume":"86","author":"M Nguyen","year":"1994","unstructured":"Nguyen, M. et al. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. natn. Cancer Inst. 86, 356\u2013361 (1994).","journal-title":"J. natn. Cancer Inst."},{"key":"BFnm019527_CR34","unstructured":"Kohn, E. et al. Phase I trial of signal transduction inhibitor, CAI. Proc. Amer. Assoc. Cancer Res. 35,244(1994)."},{"key":"BFnm019527_CR35","unstructured":"Liotta, L.A. personal communication (1994)."},{"key":"BFnm019527_CR36","unstructured":"Folkman, J. Clinical applications of angiogenesis research. New Engl. J. Med. in press (1994)."},{"key":"BFnm019527_CR37","first-page":"324a","volume":"3","author":"H Watanabe","year":"1992","unstructured":"Watanabe, H., Nguyen, M., Schizer, M., Li, V., Hayes, D.R., Sallan, S., Folkman, J. Basic fibroblast growth factor in human serum \u2013 a prognostic test for breast cancer. Molec. Biol. Cell 3, 324a (1992).","journal-title":"Molec. Biol. Cell"},{"key":"BFnm019527_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0140-6736(94)91280-7","volume":"344","author":"VW Li","year":"1994","unstructured":"Li, V.W. et al. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumors. The Lancet 344, 82\u201386 (1994).","journal-title":"The Lancet"},{"key":"BFnm019527_CR39","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1093\/jnci\/84.24.1875","volume":"84","author":"N Weidner","year":"1992","unstructured":"Weidner, N. et al. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J. natn. Cancer Inst. 84, 1875\u20131887 (1992).","journal-title":"J. natn. Cancer Inst."},{"key":"BFnm019527_CR40","first-page":"401","volume":"143","author":"N Weidner","year":"1993","unstructured":"Weidner, N., Carroll, P.R., Flax, J., Blumenfeld, W. & Folkman, J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Amer. J. Pathol. 143, 401\u2013409 (1993).","journal-title":"Amer. J. Pathol."},{"key":"BFnm019527_CR41","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/ijc.2910570624","volume":"57","author":"BA Teicher","year":"1994","unstructured":"Teicher, B.A. et al. Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents. Int. J. Cancer. 57, 920\u2013925 (1994).","journal-title":"Int. J. Cancer."},{"key":"BFnm019527_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-3092-3","volume-title":"Collateral Circulation: Heart, Brain, Kidney, Limbs","author":"W Schaper","year":"1993","unstructured":"Schaper, W., Schaper, J. Collateral Circulation: Heart, Brain, Kidney, Limbs. Kluwer Academic Publishers, Boston, (1993)."},{"key":"BFnm019527_CR43","first-page":"574","volume":"145","author":"JW Miller","year":"1994","unstructured":"Miller, J.W. et al. Vascular endothelial growth factorJVascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Amer. J. Pathol 145, 574\u2013584 (1994).","journal-title":"Amer. J. Pathol"},{"issue":"4","key":"BFnm019527_CR44","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","volume":"118","author":"Anthony P. Adamis","year":"1994","unstructured":"Adamis, A.P. et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Amer. J. Ophthal. 118, 445\u2013450(1994).","journal-title":"American Journal of Ophthalmology"},{"key":"BFnm019527_CR45","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1172\/JCI117241","volume":"93","author":"K Takahashi","year":"1994","unstructured":"Takahashi, K. et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J. clin. Invest. 93, 2357\u20132364 (1994).","journal-title":"J. clin. Invest."},{"key":"BFnm019527_CR46","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.175.4.1135","volume":"175","author":"DJ Peacock","year":"1992","unstructured":"Peacock, D.J., Banquerigo, M.L. & Brahn, E. Angiogenesis inhibition suppresses collagen arthritis. J. exp. Med. 175, 1135\u20131138 (1992).","journal-title":"J. exp. Med."},{"key":"BFnm019527_CR47","first-page":"820","volume":"44","author":"BJ Nickoloff","year":"1994","unstructured":"Nickoloff, B.J., Mitra, R.S., Varani, J., Dixit, V.M. & Polerini, P.J. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Amer. J. Pathol 44, 820\u2013828 (1994).","journal-title":"Amer. J. Pathol"},{"key":"BFnm019527_CR48","first-page":"263","volume":"103","author":"M Bacharach-Buhles","year":"1994","unstructured":"Bacharach-Buhles, M., Panz, B., Elgammal, S., Auer, T. & Altmeyer, P. The elongation of psoriatic capillaries, the result of epidermal hyperplasia, not of angiogenesis. J. Invest. Dermatol. 103, 263 (1994).","journal-title":"J. Invest. Dermatol."},{"key":"BFnm019527_CR49","first-page":"273","volume":"93","author":"S Szabo","year":"1974","unstructured":"Szabo, S. Animal model: cysteamine-induced and chronic duodenal ulcer in the rat. Amer. J. Pathol 93, 273\u2013276 (1974).","journal-title":"Amer. J. Pathol"},{"key":"BFnm019527_CR50","first-page":"1323","volume":"34","author":"S Szabo","year":"1989","unstructured":"Szabo, S. et al. Orally administered FGF mutein: Effect on healing of chronic duodenal ulcers in rats. Digestive Disease and Sciences 34, 1323 (1989).","journal-title":"Digestive Disease and Sciences"},{"key":"BFnm019527_CR51","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/00000658-199110000-00006","volume":"214","author":"J Folkman","year":"1991","unstructured":"Folkman, J. et al. Duodenal ulcer: discovery of a new mechanism and development of angiogenic therapy which accelerates healing. Ann. Surg. 214, 414\u2013427 (1991).","journal-title":"Ann. Surg."},{"key":"BFnm019527_CR52","unstructured":"Hull, M.A., Cullen, D.J.E. & Hawkey, C.J. Basic fibroblast growth factor in gastric ulceration: mucosal levels and therapeutic potential. Gastroenterology 106, A97 (1994)."},{"key":"BFnm019527_CR53","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","volume":"315","author":"H Dvorak","year":"1986","unstructured":"Dvorak, H., Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. EnglJ. Med. 315, 1650\u20131659 (1986).","journal-title":"N. EnglJ. Med."},{"key":"BFnm019527_CR54","first-page":"A212","volume":"106","author":"MM Wolfe","year":"1994","unstructured":"Wolfe, M.M. et al. Safety and efficacy of an angiogenic peptide, basic fibroblast growth factor (bFGF) in the treatment of gastroduodenal ulcers: A preliminary report. Gastroenterology 106, A212 (1994).","journal-title":"Gastroenterology"},{"key":"BFnm019527_CR55","first-page":"144","volume-title":"Steroid Hormones and Uterine Bleeding","author":"J Folkman","year":"1992","unstructured":"Folkman, J. Angiogenesis in female reproductive organs. In: Steroid Hormones and Uterine Bleeding. Alexander, N.J., d'Arcangues, C., eds. American Association for the Advancement of Science Press, Washington DC, 144\u2013158 (1992)."},{"key":"BFnm019527_CR56","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1210\/endo.131.1.1612003","volume":"131","author":"N Ravindranath","year":"1992","unstructured":"Ravindranath, N., Little-Ihrig, L., Philips, H.S., Ferrara, N. & Zeleznik, A. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology 131, 254\u2013260 (1992).","journal-title":"Endocrinology"},{"key":"BFnm019527_CR57","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2527\/1991.691237x","volume":"69","author":"DA Redmer","year":"1991","unstructured":"Redmer, D.A., Kirsch, J.D. & Reynolds, L.P. Production of mitogenic factors by cell types of bovine large estrogen-active and estrogen-inactive follicles. J. Anim. Sci. 69, 237\u2013245 (1991).","journal-title":"J. Anim. Sci."},{"key":"BFnm019527_CR58","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1096\/fasebj.6.3.1371260","volume":"6","author":"LP Reynolds","year":"1992","unstructured":"Reynolds, L.P., Killilea, D.S. & Redmer, D.A. Angiogenesis in the female reproductive system. FASEB 6, 886\u2013892 (1992).","journal-title":"FASEB"},{"key":"BFnm019527_CR59","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1095\/biolreprod41.1.175","volume":"40","author":"GS Greenwald","year":"1989","unstructured":"Greenwald, G.S. Temporal and topographic changes in DNA synthesis after induced follicular atresia. Biol. Reprod. 40, 175\u2013181 (1989).","journal-title":"Biol. Reprod."},{"key":"BFnm019527_CR60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/jnci\/82.1.4","volume":"82","author":"J Folkman","year":"1990","unstructured":"Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. natn. Cancer Inst. 82, 4\u20136 (1990).","journal-title":"J. natn. Cancer Inst."},{"key":"BFnm019527_CR61","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","volume":"91","author":"RJ D'Amato","year":"1994","unstructured":"D'Amato, R.J., Loughnan, M.S., Flynn, E. & Folkman, J. Thalidomide is an inhibitor of angiogenesis. Proc. natn Acad. Sci.USA 91, 4082\u20134085 (1994).","journal-title":"Proc. natn Acad. Sci.USA"},{"key":"BFnm019527_CR62","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1083\/jcb.103.3.1101","volume":"103","author":"W Risau","year":"1986","unstructured":"Risau, W. & Ekblom, P. Production of a heparin-binding angiogenesis factor by the embryonic kidney. J. cell Biol 103, 1101\u20131107 (1986).","journal-title":"J. cell Biol"},{"issue":"6","key":"BFnm019527_CR63","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0092-8674(93)90573-9","volume":"72","author":"B MILLAUER","year":"1993","unstructured":"Millauer, B. et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835\u2013846(1993).","journal-title":"Cell"},{"key":"BFnm019527_CR64","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/jez.1402510210","volume":"251","author":"TJ Poole","year":"1989","unstructured":"Poole, T.J. & Coffin, J.D. Vasculogenesis and angiogenesis - two distant morpho-genetic mechanisms establish embryonic vascular pattern. J. exp. Zool 251, 224\u2013231 (1989).","journal-title":"J. exp. Zool"},{"key":"BFnm019527_CR65","first-page":"997","volume":"34","author":"L Liotta","year":"1974","unstructured":"Liotta, L., Kleinerman, J. & Saidel, F. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res. 34, 997\u20131004 (1974).","journal-title":"Cancer Res."},{"key":"BFnm019527_CR66","first-page":"674","volume":"XLV","author":"H Brem","year":"1994","unstructured":"Brem, H., Goto, F., Budson, A., Saunders, L. & Folkman, J. Minimal drug resistance after prolonged antiangiogenic therapy with AGM-1470. Surgical Forum XLV, 674\u2013677 (1994).","journal-title":"Surgical Forum"},{"key":"BFnm019527_CR67","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/359845a0","volume":"359","author":"KH Plate","year":"1992","unstructured":"Plate, K.H., Breier, G., Welch, H.A. & Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359, 845\u2013848, (1992).","journal-title":"Nature"},{"key":"BFnm019527_CR68","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/bies.950130106","volume":"13","author":"RS Kerbel","year":"1991","unstructured":"Kerbel, R.S. Inhibition of tumour angiogenesis as a strategy to circumvent acquired resistance to anticancer therapeutic agents. BioEssays 13(1), 31\u201336 (1991).","journal-title":"BioEssays"},{"key":"BFnm019527_CR69","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1001\/archsurg.1992.01420110045011","volume":"127","author":"NJ Crowley","year":"1992","unstructured":"Crowley, N.J. & Siegler, H.F. Relationship between disease-free interval and survival in patients with recurrent melanoma. Arch. Surg. 127, 1303\u20131308 (1992).","journal-title":"Arch. Surg."},{"key":"BFnm019527_CR70","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1056\/NEJM199205283262203","volume":"326","author":"RAB Ezekowitz","year":"1992","unstructured":"Ezekowitz, R.A.B., Mulliken, J.B., Folkman, J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. New Engl. J. Med. 326, 1456\u20131463 (1992) (and corrections New Engl J. Med. 33, 300 (1994)).","journal-title":"New Engl. J. Med."},{"key":"BFnm019527_CR71","unstructured":"Folkman, J. et al. (unpublished data)."},{"key":"BFnm019527_CR72","unstructured":"O'Reilly, M.S. et al. (unpublished data)."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0195-27","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0195-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0195-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:29:28Z","timestamp":1684438168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0195-27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["BFnm019527"],"URL":"https:\/\/doi.org\/10.1038\/nm0195-27","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}